Background and Aims: Endoscopic and histological healing are associated with improved clinical outcomes in ulcerative colitis [UC]. We aimed to investigate the predictive value of faecal immunochemical test [FIT] for endoscopic and histological healing in UC. FIT < 50 ng/ml predicted endoscopic healing with a sensitivity, specificity, and positive predictive value [PPV] of 72%, 68%, and 82%, respectively, and for histological healing with a sensitivity, specificity, and PPV of 73-75%, 67%, and 78-80%, respectively. Combining FIT with FC led to a higher specificity [90%] for histological healing. Over 85% of patients with FIT < 50 ng/ml and FC < 50 μg/g achieved histological healing. Conclusions: FIT is highly sensitive and accurate to predict endoscopic and histological healing in UC. It represents a promising non-invasive tool for monitoring mucosal healing in UC.
Introduction
Endoscopic healing, defined as resolution of visible inflammation at colonoscopy, has been proposed as a therapeutic goal in patients with ulcerative colitis [UC] . 1 Randomised trials and cohort studies have shown that endoscopic healing is associated with long-term clinical remission, fewer hospitalisations and avoidance of colectomy in UC. 2, 3 However, endoscopic healing is not always associated with resolution of histological inflammation in patients with UC. 4, 5 Emerging studies have reported that histological healing also leads to favourable outcomes in UC. [5] [6] [7] The presence of histological inflammation in quiescent UC was an independent risk factor for disease relapse over 12 months. 8 Histological healing was also superior to endoscopic healing in predicting lower rates of corticosteroid use. 9 Importantly, a lower level of histological inflammation has been associated with a lower colectomy rate, 10 and the severity of histological inflammation was predictive for the development of colorectal neoplasia in UC. 11, 12 Currently the role of histological healing in routine clinical practice remains controversial because evaluation involves colonoscopy and multiple biopsies, which can be invasive and costly. 7 There is also a scarcity of data on whether escalating therapy based on histological inflammation leads to better outcome. Endo-microscopy has been developed to enable real-time histological assessment during endoscopy, 13, 14 but such technology is mostly limited to expert centres. Faecal calprotectin [FC] is the most widely studied non-invasive marker for determining endoscopic healing, [15] [16] [17] [18] [19] and it has a sensitivity of 67-91% and a specificity of 53-91% to predict endoscopic healing in patients with UC. [20] [21] [22] Several studies have shown that FC is also useful to assess for histological healing 4, [23] [24] [25] ; however, this test is not widely available in most countries, especially those outside Europe or North America, and in some countries it remains costly and is not reimbursed.
Faecal immunochemical test [FIT] measures haemoglobin concentration in faeces using an antibody for human haemoglobin. Because it is sensitive, cheap, and widely available, FIT has been endorsed as a primary tool for colorectal cancer [CRC] screening in most countries. 26, 27 FIT has been reported in limited studies to be useful in assessing endoscopic healing in UC. 21, 28, 29 However, its accuracy to assess for histological healing has not been determined. This prospective study compared the accuracy of FIT with FC in predicting histological healing in patients with UC.
Materials and Methods

Study design
Between October 2014 and June 2016, consecutive UC subjects aged 18-80 years, who underwent colonoscopy at the Prince of Wales Hospital, Hong Kong, were prospectively recruited. UC diagnosis was confirmed according to the Lennard-Jones criteria. 30 Patients collected the stool samples for FIT and FC measurement before bowel preparation and within 3 days of colonoscopy. Stool samples were stored at room temperature and delivered to our centre within 3 days of excretion. Clinical remission was defined as the absence of diarrhoea or rectal bleeding.
FIT and FC analyses
Patients prepared faecal samples within 3 days before colonoscopy. Samples were stored at room temperature before submission to our centre. For FIT, the OC-Sensor FIT kits [EIKEN CHEMICAL, Japan] were used. Patients were asked to dip a specifically designed sampling probe [EIKEN CHEMICAL, Japan] six times in the faeces and reinsert the probe into the respective device containing 2 ml buffer. FIT samples were stored at 4°C [median 2 days, range 1-3 days] till analysis. Specimens were tested on a qualitative FIT system [OC-SENSOR μ, EIKEN, Japan] with an analytical working range of 50-1000 ng/ml. FC specimens were stored at -80°C in a freezer till tested. We used the qualitative enzyme-linked immunosorbent assay [ELISA] kit [Inova Diagnostics, USA] to measure FC concentrations as per manufacturer's instructions. The analytical sensitivity of calprotectin was 15.6 μg/g. The assessors of FIT and FC were blinded to the clinical details of patients.
Colonoscopy
Bowel preparation was performed using polyethylene glycol solution. After the colonic lavage fluid was cleared, colonoscopy was performed by experienced endoscopists [AH, MK, and SN] who were blinded to the results of FIT and FC. Each part of the colon [right colon: proximal to hepatic flexure; transverse colon; and left colon: distal to splenic flexure] was assessed according to the Mayo endoscopic subscore [MES] . 31 The highest score among the segments was determined as the overall score. Endoscopic healing was defined as an overall MES of 0 or 1.
Histological findings
A minimum of two colonic biopsies were obtained from the site with the maximum inflammation from each colonic segment: caecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum. If no inflammation was detected at colonoscopy, two random biopsies were obtained from each segment. Histological inflammation was scaled using the Geboes score 32 and the Nancy index. 33 Histological studies were evaluated by an expert gastrointestinal [GI] pathologist [AC] with over 5 years' experience. The Geboes system is the best validated histological scoring system for UC. 6 It includes five features [structural change, chronic inflammatory infiltrate, lamina propria neutrophils and eosinophils, neutrophils in the epithelium, and crypt destruction, erosion or ulceration] and is classified on an ordinal scale as grade 0-5 [score from 0.0-5.4, with higher scores indicating more severe inflammation]. 32 The Geboes scores were converted to a continuous scale for use as a continuous variable. 8 The Nancy index includes three descriptors [ulceration, acute inflammatory cells infiltrate, and chronic inflammatory infiltrate], with the main advantages of simplicity and practicality. 33 The highest scale among the biopsies of each patient was used for analysis. Histological healing was defined as a Geboes score < 2.0 or a Nancy index ≤ 1.
Statistical analysis
The correlation between the Geboes score and Nancy index, between faecal markers and endoscopic and histological indices, were analysed using Spearman's correlation. To estimate appropriate cutoff values of FIT and FC for endoscopic and histological healing, receiver operating characteristic [ROC] analysis was performed. The area under the curves [AUCs] between FIT and FC were compared using the Delong's test. The sensitivity, specificity, positive predictive value [PPV], negative predictive value [NPV] , and accuracy were evaluated by constructing a 2 × 2 matrix, and were presented with the 95% confidence interval [CI], based on a binomial distribution. Two-sided p-values of < 0.05 were considered as significant. Statistical analysis was performed using SPSS Statistics [IBM, version 20.0].
Ethical considerations
The study was approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee. Informed consent was obtained from each patient.
Results
Patient characteristics
A total of 140 UC subjects were prospectively included. 
Correlations between FIT and endoscopic and histological findings
Sensitivity, specificity, and predictive values of FIT and FC for endoscopic healing and histological healing
Although ROC analysis showed the optimal cutoff value of FIT for endoscopic and histological healing to be 41 ng/ml and 33 ng/ml, respectively [ Figures 1 and 2 ], we set a cutoff of 50 ng/ml, because the suggested lower limit of the analytical working range of FIT was 50 ng/ml. FIT had a sensitivity of 72%, specificity of 68%, and PPV of 82% to predict endoscopic healing in UC [ A cutoff of 50 ng/ml for FIT and a cutoff of 50 μg/g for FC, based on results of the ROC analysis, were used to assess their accuracy to predict histological healing. Both FIT and FC had a sensitivity of 70-80%, a specificity of approximately 70%, and a PPV of approximately 80% for predicting histological healing. The overall accuracies of FIT and FC for histological healing were comparable [ Table 3 ].
The combination of FIT and FC resulted in an improved accuracy for histological healing. FIT < 50 ng/ml and FC < 50 μg/g had a specificity of up to 90% to predict histological healing. Among patients with FIT < 50 ng/ml and FC < 50 μg/g, over 85% achieved histological healing. and NPV, but a lower specificity and PPV for histological healing. The overall accuracies of both faecal markers and colonoscopy to predict histological healing were comparable [ Table 3 and Table 4 ].
Discussion
This prospective study found that FIT had a high sensitivity for the prediction of endoscopic and histologic healing in patients with UC, and the accuracy of FIT was comparable to that of the most commonly used stool marker, FC. The accuracy of either FIT or FC alone was not inferior to colonoscopy for the assessment of histological healing. Combining FIT to FC resulted in improved accuracy, and over 85% of UC patients with low levels of FIT and FC were found to have achieved histological healing. These findings suggest that FIT represents an alternative to FC for the assessment and monitoring of mucosal healing in patients with UC, and it may also be used when colonoscopy is not suitable or readily available. FC has been shown to effectively predict endoscopic healing, [15] [16] [17] [18] and emerging studies using heterogeneous indices have shown that it also has high predictive ability for histological healing. 4, 23, 24 Only one study, with a small sample size, had incorporated a validated histology scoring system, the Geboes score. 24 Limited studies have reported comparable accuracy between FIT and FC for endoscopic healing, but no studies have investigated FIT's accuracy for predicting histological healing. 21, 28, 34 We reported that FIT and FC had comparable accuracy in the prediction of histological healing, using two validated scoring systems. The current gold standard for histological evaluation is to perform colonoscopy, with tissue biopsies to be analysed by a pathologist, which can be inconvenient, time-consuming and costly. It is also challenging to repeat colonoscopy regularly. We found that over 85% of patients with a FIT < 50 ng/ml and a FC < 50 μg/g had achieved histological healing, suggesting that colonoscopy with multiple biopsies could be avoided in these subjects. A Japanese research team performed consecutive measurement of FIT for patients with quiescent UC and low FIT levels. It was found that all of the patients maintaining a low FIT level had sustained remission, whereas 63% of the patients with positive conversion of FIT experienced clinical relapse. 35 They also reported that a higher level of FIT predicted a higher risk for disease relapse. 36 FIT has several advantages over FC. First, FC is not widely available in most countries, and in some countries it is still costly and not reimbursed. In contrast, FIT is much cheaper and widely available worldwide. The cost of a one-off FIT assessment is USD26 in Hong Kong, whereas that of FC is approximately USD200. As UC is a lifelong chronic illness and mucosal healing is the therapeutic goal, FIT is economically more suitable than colonoscopy or FC for repeated measurements. The cost-effectiveness of FIT as a monitoring tool in UC, however, remains to be determined. Second, the analysis for FIT is much easier than that for FC. Most available FC is analysed by ELISA, which requires specific skills and takes several hours to perform. The stool processing step is also unpleasant and time-consuming. In contrast, for FIT, samples can be automatically analysed by setting the kit tube into the equipment, without the need for any other operation by technicians, and the results can be available within 10 min. Third, patients only need to insert the sampling probe into several different areas of the stool, instead of collecting stool as they do to prepare for the FC test. It has been reported that patients' disinclination to collect stool is a limitation for accepting most faecal marker tests. 15 The convenience of preparing a stool specimen for FIT may increase the uptake rate. Given a comparable accuracy to FC, FIT has potential to become a promising tool for disease monitoring in UC.
Histological healing is associated with improved clinical outcomes, including prolonged remission, 8, 37 reduced need for hospitalisation, 9 lower risk of surgery, 10 and reduced cancer development. 11, 12 However, to date there is no universal definition for histological healing, and the terms 'histological healing' and 'histological remission' appeared interchangeable. 5, 6 Some studies used Geboes score < 2.0 [no acute inflammation] for histological remission, 38 and others defined histological activity as a Geboes score ≥ 3.1 [neutrophils in epithelium/crypt, but not scoring neutrophils in lamina propria]. 8, 39 Since it has been reported that acute inflammatory cell infiltrate [including in lamina propria] predicts disease relapse, 37, 40 we used a more stringent definition-Geboes score < 2.0─for histological healing. The Nancy index does not define acute inflammation by the location of neutrophils. 33 A Nancy grade ≤ 1 corresponds to a Geboes score of < 2.0 by the definitions of both systems. 32, 33 To the best of our knowledge, this represents the first study to investigate the role of FIT to predict histological healing in UC. We compared its accuracy with FC, the most well-characterised surrogate indicator, and colonoscopy, the gold standard for endoscopic healing, and found that FIT is not inferior to either FC or colonoscopy for histological healing. Importantly, by combining FIT with FC, over 85% of colonoscopy with multiple biopsies could be avoided in patients with low levels of both markers. We also evaluated the histological status of UC using two validated scoring systems. The Geboes score is a validated histological scaling system, 6 and the Nancy index represents a simple tool for histological assessment in UC. 33 Our study showed that the two systems had a high concordance. Being a user-friendly and reliable tool, the Nancy index has the potential to be widely used for assessing histological inflammation of UC in clinical practice.
There were a few limitations of our study. First, the sample size was relatively small, and it will be important to validate our results in an independent cohort. It was also underpowered to evaluate the performance of FIT in exclusively clinically quiescent patients, who would represent a more suitable group of candidates for assessing mucosal healing; nonetheless, about three-quarters of patients included were in clinical remission at the time of the tests. 41 A small proportion of patients with active disease in our study may explain a lower level of FC reaching the best cutoff value, compared with previous studies. 17, 20, 42 Second, endoscopic healing was defined as MES 0/1 in our study, consistent with the definition used in many clinical trials. [43] [44] [45] Emerging studies have reported that the risk for disease relapse is significantly lower in patients achieving MES 0, compared with the risk in those with MES 1. 46, 47 We assessed the performance of FIT and FC in predicting MES 0, and found no significant difference between the two tests.
Third, disease extent was heterogeneous in our study, with proctitis in 25% of the patients. It has been reported that FC is not sensitive in patients with limited proctitis. 48 Subgroup analyses were performed to assess the value of FC to predict endoscopic healing, excluding patients with proctitis [Supplementary Table 2 Fourth, we did not examine the inter-observer variation for the interpretation of the Geboes score or Nancy index. All of the histological examinations in our study were performed by one single experienced gastrointestinal pathologist with at least 5 years' experience. However, it has been reported that both Geboes system and Nancy index have good inter-observer reliability. 32, 33 Finally, no longitudinal data were available to assess the value of FIT in the prediction for disease relapse in our present study. It has been reported by one Japanese research team that a higher level of FIT predicts a higher risk for disease relapse. 35 Studies in larger populations and longitudinal data are needed to validate the cutoff of FIT and choose the right nodes in the management algorithms for using the test.
In conclusion, our study revealed that FIT is a reliable noninvasive marker for both endoscopic and histological healing in patients with UC. Repeated colonoscopy with multiple biopsies can be avoided in over 85% of patients with low levels of both FIT and FC. Being an accurate, cheap and convenient tool, FIT represents a promising non-invasive stool marker for disease monitoring in UC. 
